SiNtx Technologies Inc. (SINT) is a Medical/Dental Instruments company listed on NASDAQ. In the last 30 days Quantisnow tracked 5 wire items for SINT, including 3 SEC filings and 2 earnings updates. The most recent was published Nov 5, 2026.
Financial highlights
Full financials- Revenue, TTM
- $3.31M
- Revenue growth
- +160.8%
- Net income, TTM
- -$9.34M
- Net margin
- -281.9%
- Free cash flow, TTM
- -$9.25M
- Cash
- $2.00M
For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks27+67%
2026-05-172026-11-08
Mix1690d
- SEC Filings9(56%)
- Other5(31%)
- Earnings2(13%)
Activity · 52 weeks5136 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- SECSiNtx Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Sintx Technologies, Inc. (0001269026) (Filer)
- SECSEC Form 10-Q filed by SiNtx Technologies Inc.10-Q - Sintx Technologies, Inc. (0001269026) (Filer)
- PRSINTX Reports Record Third Quarter 2026 Revenue Growth and Advances Medical Device CommercializationThird quarter revenue increases more than tenfold year over year, while operating losses decrease 51% as Company advances commercialization of its proprietary silicon nitride technologies SALT LAKE CITY, Utah, Nov. 05, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a global leader in advanced silicon nitride biomaterials and ceramics for medical and industrial applications, today announced its financial results and business highlights for the third quarter ended September 30, 2026. Third Quarter Financial Results ●For the three months ended September 30, 2026, total revenue increased to approximately $2.2 million, compared with $208,000 durin
- SECSEC Form DEF 14A filed by SiNtx Technologies Inc.DEF 14A - Sintx Technologies, Inc. (0001269026) (Filer)
- PRSINTX Technologies Announces Third Quarter 2026 Earnings Release Date and WebcastSALT LAKE CITY, Utah, Oct. 22, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a leader in advanced silicon nitride biomaterials and ceramics for medical and industrial applications, today announced that it will release its third quarter 2026 financial results on Thursday, November 5, 2026, after the market close. The Company will also host a conference call and webcast that day at 4:30 p.m. ET to review the Company’s third quarter 2026 performance. Management participants will include Eric Olson, Chief Executive Officer and Chairman of the Board, and Kevin Trask, Chief Financial Officer. Interested parties may access the conference call and web
- SECSEC Form 8-K filed by SiNtx Technologies Inc.8-K - Sintx Technologies, Inc. (0001269026) (Filer)
- SECSiNtx Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Sintx Technologies, Inc. (0001269026) (Filer)
- PRSINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End GuidanceThird-quarter revenue grows roughly 380% from Q2, driven by stronger-than-expected industrial sales to Fortune 500 customers; Company reiterates Q4 revenue guidance Revenue milestone also enables Company to call Class B warrants SALT LAKE CITY, Utah, Oct. 01, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a leader in advanced silicon nitride biomaterials and ceramics for medical and industrial applications, today announced preliminary, unaudited revenue of $2.2 million* for the third quarter ended September 30, 2026. The result exceeds the high end of the Company’s previously announced guidance of $0.9 million to $1.1 million, reflecting stro
- PRSINTX Technologies Announces Silicon Nitride Masterclass with Leading Orthopedics ExpertsExperts in implant retrieval, biomaterials and clinical practice examine the science, clinical experience and potential advantages of silicon nitride relative to established implant materials in Company-sponsored Orthopedics This Week Masterclass SALT LAKE CITY, Utah, Sept. 14, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company commercializing proprietary silicon nitride technologies across medical and other high-value applications, today announced the availability of a Company-sponsored Masterclass hosted by Orthopedics This Week ("OTW"), the most widely read publication in the orthopedics industry, th
- PRSINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment ConferenceSALT LAKE CITY, Utah, Sept. 08, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company commercializing proprietary silicon nitride technologies across medical and other high-value applications, today announced that it will participate in the 28th Annual H.C. Wainwright Global Investment Conference, taking place September 14–16, 2026, at the Lotte New York Palace Hotel in New York City. Gregg Honigblum, Chief Investment Officer, and Ryan Elmore, President of SINTX, will deliver a company presentation and participate in one-on-one meetings with investors throughout the conference. The presentation will highli
- SECSEC Form EFFECT filed by SiNtx Technologies Inc.EFFECT - Sintx Technologies, Inc. (0001269026) (Filer)
- SECSiNtx Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - Sintx Technologies, Inc. (0001269026) (Filer)
- PRSINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity RequirementSALT LAKE CITY, Utah, Aug. 13, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a company focused on advanced silicon nitride materials and medical technologies, today announced that it received written notification from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on the Nasdaq Capital Market to maintain minimum stockholders’ equity of $2.5 million. Based on SINTX’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, which reported stockholders’ equity of approximately $4.83 million
- SECSiNtx Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Sintx Technologies, Inc. (0001269026) (Filer)
- SECSEC Form 10-Q filed by SiNtx Technologies Inc.10-Q - Sintx Technologies, Inc. (0001269026) (Filer)
- PRSINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth InitiativesSALT LAKE CITY, Utah, Aug. 11, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a leader in advanced silicon nitride biomaterials and ceramics for medical and industrial applications, today provided a business update in conjunction with the filing of its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026. During the first half of 2026, SINTX advanced the commercialization of its FDA-cleared SiNAPTIC® Foot & Ankle Implant System, expanded its commercial distribution network, raised additional capital, invested in advanced manufacturing capabilities, and continued to broaden the application of its proprietary silicon nitride technolo
- PRSINTX Technologies Announces Second Quarter 2026 Earnings Release Date and WebcastSALT LAKE CITY, Utah, July 28, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a leader in advanced silicon nitride ceramics and advanced material technologies, today announced that it will release its second quarter 2026 financial results on Tuesday, August 11, 2026, after the market close. The Company will also host a conference call and webcast that day at 4:30 p.m. ET to review the Company’s second quarter 2026 performance. Management participants will include Eric Olson, Chief Executive Officer and Chairman of the Board, and Kevin Trask, Chief Financial Officer. Interested parties may access the conference call and webcast as follows: Webc
- SECSiNtx Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Sintx Technologies, Inc. (0001269026) (Filer)
- PRSINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management ProgramSALT LAKE CITY, Utah, July 23, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a leader in advanced biomaterials and silicon nitride technologies for medical device and industrial applications, today announced that it has engaged Southern Metrics Consulting ("Southern Metrics") to assist the Company in identifying, evaluating, and pursuing strategic opportunities intended to enhance stockholder value. Southern Metrics is led by Chris Lyons, its Chief Executive Officer, an experienced medical technology executive and strategic advisor who has served on the SINTX Board of Directors since April 2025. Southern Metrics will establish and manage the Co
- SECSiNtx Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Sintx Technologies, Inc. (0001269026) (Filer)
- SECSEC Form EFFECT filed by SiNtx Technologies Inc.EFFECT - Sintx Technologies, Inc. (0001269026) (Filer)
- SECSEC Form S-3 filed by SiNtx Technologies Inc.S-3 - Sintx Technologies, Inc. (0001269026) (Filer)
- PRSINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase OrdersSALT LAKE CITY, Utah, June 22, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a leader in advanced silicon nitride ceramics and advanced material technologies, today announced that it has received purchase orders from multiple contract manufacturing customers with an aggregate value exceeding $3.2 million for the production of advanced ceramic components. SINTX’s advanced ceramic manufacturing platform supports customers across multiple industries requiring high-performance materials with demanding mechanical, thermal, and chemical properties. The Company’s expertise in silicon nitride technologies positions it to support both proprietary produ
- SECSEC Form SCHEDULE 13G filed by SiNtx Technologies Inc.SCHEDULE 13G - Sintx Technologies, Inc. (0001269026) (Subject)
- SECSiNtx Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits8-K - Sintx Technologies, Inc. (0001269026) (Filer)
SINT FAQ
11 questionsWhat does SiNtx Technologies Inc. do?
Sintx Technologies, Inc., an advanced materials company, researches, develops, manufactures, and commercializes silicon nitride ceramics in the United States, Europe, and South America. It offers ceramic based solutions for various medical, industrial, and antipathogenic applications. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products. It has a collaboration agreement with Oxford Performance Materials, Inc. to develop a poly-ether-ketone-ketone silicon nitride composite based on OXPEKK SC solution casting technology. The company...What is the latest news on SINT?
In the last 30 days Quantisnow tracked 5 wire items for SINT: 3 SEC filings and 2 earnings updates. The most recent was published on November 5, 2026.What is SINT revenue?
SiNtx Technologies Inc. (SINT) reported $3.31M of revenue for the twelve months ended Sep 30, 2026. That is up 160.8% from the year before. Revenue for fiscal 2025 was $1.02M.Is SINT profitable?
No. SiNtx Technologies Inc. reported a net loss of $9.34M for the twelve months ended Sep 30, 2026.How much cash and debt does SINT have?
SiNtx Technologies Inc. reported $2.00M in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does SINT stock trade?
SiNtx Technologies Inc. (SINT) is listed on NASDAQ.What sector and industry is SINT in?
SiNtx Technologies Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did SiNtx Technologies Inc. go public?
SiNtx Technologies Inc. (SINT) completed its IPO in 2014.What are analysts saying about SINT?
SiNtx Technologies Inc. has had 1 recent analyst action on file. The most recent action was from H.C. Wainwright: Buy with a $10.00 price target on 2026-04-13. Recent price targets cluster around $10.00.What companies are similar to SINT?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare SINT side-by-side with any of them on Quantisnow.How can I track SINT on Quantisnow?
Quantisnow aggregates SiNtx Technologies Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SINT to receive live email and push alerts on every new disclosure.